TickerFacts.

Fulgent Genetics, Inc. (FLGT): Revenue

Annual figures by period end, from SEC filings.

$322.67M
Year ended 2025-12-31
$323.93M
Trailing 12 months to 2026-06-30
-19.5%
3-year compound annual growth
-5.2%
5-year compound annual growth
+42.2%
10-year compound annual growth
$992.58M2014-12-31: $1.28M2015-12-31: $9.58M2016-12-31: $18.28M2017-12-31: $18.73M2018-12-31: $21.35M2019-12-31: $32.53M2020-12-31: $421.71M2021-12-31: $992.58M2022-12-31: $618.97M2023-12-31: $289.21M2024-12-31: $283.47M2025-12-31: $322.67M$322.67M
2014-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$322.67M+13.8%2026-02-27, From 2025-01-01
2024-12-31$283.47M-2.0%2026-02-27, From 2024-01-01
2023-12-31$289.21M-53.3%2026-02-27, From 2023-01-01
2022-12-31$618.97M-37.6%2025-02-28, From 2022-01-01
2021-12-31$992.58M+135.4%2024-02-28, From 2021-01-01
2020-12-31$421.71Mn/m2023-02-28, From 2020-01-01
2019-12-31$32.53M+52.3%2022-02-28, From 2019-01-01
2018-12-31$21.35M+14.0%2020-03-13, From 2018-01-01
2017-12-31$18.73M+2.5%2019-03-22, From 2017-01-01
2016-12-31$18.28M+90.9%2018-03-20, From 2016-01-01
2015-12-31$9.58M+649.3%2017-03-17, From 2015-01-01
2014-12-31$1.28Mn/a2017-03-17, From 2014-01-01

Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Fulgent Genetics, Inc. (FLGT)2025-12-31$322.67M+13.8%
BillionToOne, Inc. (BLLN)2025-12-31$305.11M+100.0%
Castle Biosciences Inc (CSTL)2025-12-31$344.23M+3.7%
CareDx, Inc. (CDNA)2025-12-31$379.81M+13.8%
Veracyte, Inc. (VCYT)2025-12-31$517.14M+16.0%
GRAIL, Inc. (GRAL)2025-12-31$147.17M+17.2%
Caris Life Sciences, Inc. (CAI)2025-12-31$812.03M+97.0%
Guardant Health, Inc. (GH)2025-12-31$982.02M+32.9%
Biodesix Inc (BDSX)2025-12-31$88.50M+24.1%

Compare FLGT, BLLN, CSTL, CDNA side by side · Screen every company in Services-Medical Laboratories ↗